ROMJF
Price
$0.34
Change
+$0.01 (+3.03%)
Updated
Jul 3 closing price
Capitalization
19.9M
RSCI
Price
$0.07
Change
-$0.10 (-58.82%)
Updated
May 13 closing price
Capitalization
N/A
Interact to see
Advertisement

ROMJF vs RSCI

Header iconROMJF vs RSCI Comparison
Open Charts ROMJF vs RSCIBanner chart's image
Rubicon Organics
Price$0.34
Change+$0.01 (+3.03%)
Volume$12.2K
Capitalization19.9M
Redwood Scientific Technologies
Price$0.07
Change-$0.10 (-58.82%)
Volume$13.39K
CapitalizationN/A
ROMJF vs RSCI Comparison Chart in %
Loading...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROMJF vs. RSCI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROMJF is a Hold and RSCI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ROMJF: $0.34 vs. RSCI: $0.07)
Brand notoriety: ROMJF and RSCI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ROMJF: 73% vs. RSCI: 105%
Market capitalization -- ROMJF: $19.9M vs. RSCI: $0
ROMJF [@Pharmaceuticals: Other] is valued at $19.9M. RSCI’s [@Pharmaceuticals: Other] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROMJF’s FA Score shows that 0 FA rating(s) are green whileRSCI’s FA Score has 0 green FA rating(s).

  • ROMJF’s FA Score: 0 green, 5 red.
  • RSCI’s FA Score: 0 green, 5 red.
According to our system of comparison, ROMJF is a better buy in the long-term than RSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROMJF’s TA Score shows that 4 TA indicator(s) are bullish while RSCI’s TA Score has 1 bullish TA indicator(s).

  • ROMJF’s TA Score: 4 bullish, 4 bearish.
  • RSCI’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, both ROMJF and RSCI are a good buy in the short-term.

Price Growth

ROMJF (@Pharmaceuticals: Other) experienced а +9.68% price change this week, while RSCI (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

ROMJF is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROMJF YTD gains are higher at: 3.912 vs. RSCI (-32.432).
ROMJFRSCIROMJF / RSCI
Capitalization19.9MN/A-
EBITDA1.21MN/A-
Gain YTD3.912-32.432-12%
P/E RatioN/AN/A-
Revenue39.2MN/A-
Total Cash7.6MN/A-
Total Debt10.4MN/A-
FUNDAMENTALS RATINGS
ROMJF vs RSCI: Fundamental Ratings
ROMJF
RSCI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
5693
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSCI's Valuation (36) in the null industry is in the same range as ROMJF (41). This means that RSCI’s stock grew similarly to ROMJF’s over the last 12 months.

RSCI's Profit vs Risk Rating (100) in the null industry is in the same range as ROMJF (100). This means that RSCI’s stock grew similarly to ROMJF’s over the last 12 months.

ROMJF's SMR Rating (90) in the null industry is in the same range as RSCI (100). This means that ROMJF’s stock grew similarly to RSCI’s over the last 12 months.

ROMJF's Price Growth Rating (56) in the null industry is somewhat better than the same rating for RSCI (93). This means that ROMJF’s stock grew somewhat faster than RSCI’s over the last 12 months.

ROMJF's P/E Growth Rating (100) in the null industry is in the same range as RSCI (100). This means that ROMJF’s stock grew similarly to RSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ROMJFRSCI
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 3 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSBC33.700.42
+1.26%
WesBanco
NRT5.100.02
+0.39%
North European Oil Royalty Trust
EICB25.040.01
+0.04%
Eagle Point Income Company
HIFS275.21N/A
N/A
Hingham Institution for Savings
EAT182.77-1.25
-0.68%
Brinker International

ROMJF and

Correlation & Price change

A.I.dvisor tells us that ROMJF and SGIOF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMJF and SGIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROMJF
1D Price
Change %
ROMJF100%
+4.20%
SGIOF - ROMJF
8%
Poorly correlated
N/A
SGIOY - ROMJF
8%
Poorly correlated
-2.15%
RSCI - ROMJF
5%
Poorly correlated
N/A
TEVJF - ROMJF
4%
Poorly correlated
N/A
PCLOF - ROMJF
3%
Poorly correlated
+37.05%
More

RSCI and

Correlation & Price change

A.I.dvisor tells us that RSCI and ETST have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCI and ETST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCI
1D Price
Change %
RSCI100%
N/A
ETST - RSCI
22%
Poorly correlated
-7.14%
RAFA - RSCI
7%
Poorly correlated
N/A
SGIOF - RSCI
6%
Poorly correlated
N/A
TEVJF - RSCI
5%
Poorly correlated
N/A
SBFM - RSCI
5%
Poorly correlated
-6.06%
More